National Cancer Institute
Found 38 results for your search:
Relevant funding data is only available when one cancer type or one research topic is selected.
Fiscal Year FY 2011
NIH Funding Mechanism [K23]
Modify this Search New Search
Close

Modify Search Criteria

Some search criteria may be modified to refine your current search.

Select criteria to modify:

Add or remove search options:

Select criteria above to see additional search options

Cancel
Showing 1 - 38 of 38 results
Clipboard
Project Title Sorted ascending Project Number Funded Amount Principal
Investigator
Institution
1
Adherence to the HCT Medical Regimen: Influence of Cancer Patient-Cargiver Dyads 1K23CA149082-01A1 $106,276 POSLUSZNY, DONNA UNIVERSITY OF PITTSBURGH AT PITTSBURGH
2
Allogeneic stem cell transplant with grafts depleted of naive T cells for leukemi 1K23CA154532-01 $169,590 Bleakley, Marie FRED HUTCHINSON CANCER RESEARCH CENTER
3
Augmenting Cancer Vaccine Therapy with TLR9 agonists 5K23CA125205-05 $138,348 Adams, Sylvia NEW YORK UNIVERSITY SCHOOL OF MEDICINE
4
Bone Marrow Micrometastatic Disease in Ewing Sarcoma 1K23CA154530-01 $163,976 DuBois, Steven UNIVERSITY OF CALIFORNIA SAN FRANCISCO
5
Childhood Cancer Survivor Program to Empower Action in Care (CC-SPEAC) 5K23CA124451-04 $143,556 Sharp, Lisa UNIVERSITY OF ILLINOIS AT CHICAGO
6
CT Volume Measurement of Lung Cancer treated with Erlotinib: Genomic Correlation 1K23CA157631-01A1 $180,360 Nishino, Mizuki BRIGHAM AND WOMEN'S HOSPITAL
7
Defining clinical efficacy and markers predicting response to bortezomib in AML 5K23CA118419-05 $143,370 Attar, Eyal MASSACHUSETTS GENERAL HOSPITAL
8
Dissecting the mechanisms of immune tolerance within the pancreatic tumor's micro 5K23CA148964-02 $178,200 Zheng, Lei JOHNS HOPKINS UNIVERSITY
9
Effects of Antioxidant Supplementation during Breast Cancer Adjuvant Therapy 5K23CA141052-03 $152,763 GREENLEE, HEATHER COLUMBIA UNIVERSITY HEALTH SCIENCES
10
Enhancing T-Cell Responses with the Glutathione Mimetic NOV-002 in Breast Cancer 5K23CA148893-02 $159,614 MONTERO, ALBERTO UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
11
Epigenetic markers involved in colorectal cancer recurrence and metastases 5K23CA127141-04 $140,940 AHUJA, NITA JOHNS HOPKINS UNIVERSITY
12
Gene Modified Dendritic Cell Therapy in Lung Cancer 5K23CA131577-03 $132,031 Lee, Jay UNIVERSITY OF CALIFORNIA LOS ANGELES
13
Heat Shock Protein Vaccine Targeting Carbonic Anhydrase IX in Renal Cell Carcinom 5K23CA120075-06 $146,059 KIM, HYUNG CEDARS-SINAI MEDICAL CENTER
14
HIV, Gut Mucosal Turnover and Inflammation, and the Risk of Colorectal Neoplasia 1K23CA157929-01A1 $171,720 Somsouk, Ma UNIVERSITY OF CALIFORNIA SAN FRANCISCO
15
Homeostatic proliferation and regulatory T cell depletion as cancer immunotherapy 5K23CA133196-04 $129,843 Kline, Justin UNIVERSITY OF CHICAGO
16
Human Herpesvirus-8 Replication and Kaposi Sarcoma Response to Treatment 1K23CA150931-01A1 $141,301 Phipps, Warren FRED HUTCHINSON CANCER RESEARCH CENTER
17
Improving current therapies for myeloma 5K23CA130074-03 $172,368 VOGL, DAN UNIVERSITY OF PENNSYLVANIA
18
Inhibiting EGFR and ER pathways in NSCLC 1K23CA149079-01A1 $165,240 GARON, EDWARD UNIVERSITY OF CALIFORNIA LOS ANGELES
19
Innate Immunity and Cancer Therapy 5K23CA122830-05 $139,012 COOLEY, SARAH UNIVERSITY OF MINNESOTA TWIN CITIES
20
Metformin as a Novel Chemotheraeutic Strategy for the Treatment of Endometrial Ca 5K23CA143154-02 $170,873 Bae-Jump, Victoria UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
21
Methylation and Hepatocellular Carcinoma Outcomes 1K23CA149084-01A1 $171,180 Siegel, Abby COLUMBIA UNIVERSITY HEALTH SCIENCES
22
MicroRNA profiling to predict recurrence after resection of early lung cancer 1K23CA149076-01A1 $189,000 Yendamuri, Saikrishna ROSWELL PARK CANCER INSTITUTE CORP
23
mTOR Inhibition as a Therapeutic Strategy for Acute Myeloid Leukemia 5K23CA141054-02 $172,368 PERL, ALEXANDER UNIVERSITY OF PENNSYLVANIA
24
Nanoscale analysis of proteomic response to novel targeted therapies for lymphoma 5K23CA140722-02 $173,448 FAN, ALICE STANFORD UNIVERSITY
25
Novel Immunotherapeutic Approaches and Tools Utilizing Allogeneic T Cells 5K23CA129679-03 $177,525 SYMONS, HEATHER JOHNS HOPKINS UNIVERSITY
26
Novel Biologic Therapies for Hodgkin's Lymphoma 5K23CA124465-04 $140,940 KASAMON, YVETTE JOHNS HOPKINS UNIVERSITY
27
Novel systemic therapy to improve clinical outcome in small cell lung cancer 1K23CA164015-01 $163,552 Owonikoko, Taofeek EMORY UNIVERSITY
28
Optimizing localized therapy for primary liver cancer: a clinical trial and model 5K23CA139005-03 $169,199 Miksad, Rebecca BETH ISRAEL DEACONESS MEDICAL CENTER
29
PARP Inhibition to Treat Triple-Negative Breast Cancer Brain Metastases 1K23CA157728-01 $173,621 Anders, Carey UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
30
Radioguided Detection of Lymph Node Metastasis in Non-Small Cell Lung Cancer 5K23CA122182-04 $148,505 NWOGU, CHUKWUMERE ROSWELL PARK CANCER INSTITUTE CORP
31
Reducing Missed And Delayed Diagnoses In Cancer: Lessons From Aviation 5K23CA125585-05 $141,750 SINGH, HARDEEP BAYLOR COLLEGE OF MEDICINE
32
Risk reduction through polyamine inhibition among colorectal carcinoma patients 5K23CA133142-03 $178,465 Zell, Jason UNIVERSITY OF CALIFORNIA IRVINE
33
Src inhibition in Colorectal Cancer 5K23CA136980-04 $134,796 KOPETZ, EDMUND UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
34
Targeted Therapies in Breast Cancer 5K23CA127469-03 $163,944 Mayer, Ingrid VANDERBILT UNIVERSITY
35
Targeting Akt Activation in CLL 1K23CA160345-01 $167,400 Ding, Wei MAYO CLINIC
36
Targeting Leukemia Stromal Interactions in AML 5K23CA140707-03 $158,533 UY, GEOFFREY WASHINGTON UNIVERSITY
37
Therapeutic approaches that target cancer cell metabolism 5K23CA120862-04 $137,295 AMARAVADI, RAVI UNIVERSITY OF PENNSYLVANIA
38
Translational Medicine and Cancer Therapy with Vasculature-Targeted Agents 5K23CA124802-05 $129,843 Maitland, Michael UNIVERSITY OF CHICAGO
Relevant funding data is only available when one cancer type or one research topic is selected.
Showing 1 - 38 of 38 results
Go to top